GRPR and neoplasm: With the lowest initial uptake in PC-3 tumor xenografts among all evaluated radioligands, the clinically evaluated GRPR agonist [177Lu]Lu-AMBA also had the lowest absorbed dose in PC-3 tumor xenografts (79.1 mGy/MBq).